Sign in / Join Now
ETFs & Funds
Don't I feel like an idiot. I still think it's a long-term buy. Great pipeline and collaborations with GSK, Bayer. $
tough to catch a falling knife
OMED will struggle till years end due to a lack of clinical trials and steady 6mos 3-stage unlocking of IPO shares. After that Up Up Up!
Add a reply...
Latest StockTalks »
people get OMED breaking news and analysis by email alert.
Get email alerts on OMED »
OncoMed Pharmaceuticals, Inc
Get latest price
From other sites
OncoMed Announces Year-End Cash Balance And 2017 Outlook
at TheStreet (Jan 5, 2017)
OncoMed Initiates Enrollment Of Phase 1b Clinical Trial Of Anti-DLL4/VEGF Bispecific Antibody As Second-line Treatment For Metastatic Colorectal Cancer Patients
at TheStreet (Jan 4, 2017)
Are Options Traders Betting on a Big Move in OncoMed (OMED) Stock?
at Zacks.com (Dec 27, 2016)
Noteworthy Monday Option Activity: OMED, NKTR, MNKD
at TheStreet (Dec 19, 2016)
OncoMed Announces Departure Of Chief Medical Officer
at TheStreet (Dec 5, 2016)